
MD & PhD, Institute of Infection, Immunity and Inflammation, @UofGlasgow, UK, J-STAR IR & AYR member
Joined October 2021
- Tweets139
- Following86
- Followers60
- Likes515
I am very delighted that our EGPA case report is published in Frontiers in Immunology!
frontiersin.org/journals/imm…
Yuriko Yamamura retweeted
🌟 Don't miss out on our EULAR–EMEUNET webinar: "From Gut to Joint – Essential Insights for Rheumatologists & Gastroenterologists" happening today! 🌟
🗓️ 9 Sept 2025 | ⏰ 19:00–20:00 CEST
👉 Secure your spot now: pulse.ly/ilg2ltxbfw
#Rheumatology #IBD #EULAR #EMEUNET
Yuriko Yamamura retweeted
J-STAR presents🎆✨
Mark your calendar for Day2 break time 🗓️👇
Please visit #AYR booth for a special chance to network and make friends❣️
We’ll have a taste of Japanese culture🇯🇵
#AYR #JSTAR #APLAR2025 @JCRheum @APLAR_org
Yuriko Yamamura retweeted
Our paper is out!
We show that GM-CSF drives early bone damage in RA—even before arthritis begins—and that JAK inhibitors can suppress this progression.
A long journey, but worth it!
doi.org/10.1186/s13075-025-0…
Yuriko Yamamura retweeted
【学習資材公開のお知らせ】
厚生労働省科学研究費補助金(免疫・アレルギー疾患政策研究事業)患者視点に立ったリウマチ疾患のアンメットメディカルニーズの「見える」化と社会実装に資する研究班にて、講談社との連携により学習資材「はたらく細胞 関節リウマチ・若年性特発性関節炎における関節炎の病態と抗リウマチ薬の作用機序」が制作されました!
本企画では、新たに作成した滑膜細胞、破骨細胞のキャラクターが登場します。
是非医療や教育の場でご活用ください。
詳細、ダウンロードはこちら▼
ryumachi-jp.com/publish/othe…
#JCR
#日本リウマチ学会
#はたらく細胞
#学習資材
#関節リウマチ
#若年性特発性関節炎
Yuriko Yamamura retweeted
Drinking more than 3 cups of coffee, especially in the mornings rather than throughout the day, may be one of the easiest ways to increase survival! Hurray for coffee…in the mornings 🤪☕️
academic.oup.com/eurheartj/a…
Yuriko Yamamura retweeted
👇Summery of AAV session
#EULAR2024
Yuriko Yamamura retweeted
We urge all delegates to check with your local embassies concerning visa requirements as regulations may vary, and begin the visa application process in advance.
Stay informed about your visa and travel requirements: tinyurl.com/APLAR24-Visa
Yuriko Yamamura retweeted
最新号のMRでは、IgG4関連疾患では稀とされてきた、血清IgAが高い群について報告されています。全体の10.1%で認められ、グルココルチコイドに対する反応が良好で、再発頻度が低いことが示されました。(SS)
doi.org/10.1093/mr/road056
#JCR
#日本リウマチ学会
#MR論文紹介
Very happy to receive the @TenovusScotland grant! Looking forward to working on it🥳
Yuriko Yamamura retweeted
Contribute to the 26th Asia Pacific League of Associations for Rheumatology Congress with our variety of sponsorship opportunities.
For additional information on how to collaborate with us, reach out to Thomas Howden at +61 2 9213 4016 or thomas.howden@wearemci.com.
Yuriko Yamamura retweeted
グルココルチコイドの新たな抗炎症機序。
副作用の少ない治療につながるか。
natureasia.com/ja-jp/nature/…
Yuriko Yamamura retweeted
Attend the #APLAR24 Immunology Workshop and explore topics such as the overall view of the immune system, #eosinophils, #neutrophils, #autoimmunity, and #immunodeficiency with in-depth insights and discussions
Register now at an additional cost of $75: tinyurl.com/APLARWorkshop
Yuriko Yamamura retweeted
#APLAR24 Speaker Highlight!
Prof. Harigai is the principal investigator for the 2020 Japanese Clinical Practice Guidelines for Rheumatoid Arthritis, a clinical trial of tocilizumab for ANCA-associated vasculitis.
More about the Speakers: tinyurl.com/APLAR24-Viewspea…





















